BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, June 6, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 16, 2020
View Archived Issues
3D spheroid cultures of primary human hepatocytes may improve the screening of CYP3A4 induction
Read More
Inhibition of the BDNF-TrkB pathway shows pain recession effect in a rat model
Read More
Zydus reports positive phase II data for PegiHep in patients with COVID-19 in India
Read More
First patient dosed in phase I study of BBP-398
Read More
University of North Carolina patents CAR compositions targeting carbonic anhydrase IX
Read More
RNA drugging strategies beyond oligos shaping up
Read More
Bayer, The Broad Institute identify new KAT6A and/or KAT6B inhibitors
Read More
Phase II data presented for SHR-1314 in patients with plaque psoriasis
Read More
Reversal of pumping direction is reversal of fortune for tumor cells
Read More
New alpha-protein kinase 1 activators discovered at Shanghai Yaoyuan Biotechnology
Read More
Heart development protein has role in adult immunity
Read More
Jiangsu Simcere Pharmaceutical R&D discloses new EGFR inhibitors
Read More
Positive data from two pooled post-hoc analyses of phase III ORION trials of inclisiran
Read More
New integrated stress response pathway modulators synthesized at Evotec International
Read More
CEA-Cupid/[211At]Psyche-B: a pretargeting system for radionuclide therapy of CEA-positive tumors
Read More
ObsEva reports topline phase IIa data on ebopiprant to treat preterm labor
Read More
First phase I data presented for retifanlimab in patients with advanced solid tumors
Read More
FDA complete response letter for sutimlimab cites third-party manufacturing issues
Read More
OSE Immunotherapeutics' agonist monoclonal antibody OSE-230 designed to resolve inflammation
Read More
Phase II CALAVI trials of Calquence in COVID-19 do not meet primary efficacy endpoint
Read More
Phase III study of mRNA-1273 for COVID-19 meets primary efficacy endpoint at interim analysis
Read More
FDA grants accelerated approval to Keytruda with chemotherapy for TNBC
Read More
Tonix reports preliminary nonhuman primate data on COVID-19 vaccine candidate TNX-1800
Read More
Vicore Pharma opens enrollment in phase II study of C-21 for IPF
Read More
